LifeStance Therapists & Psychiatrists San Marcos
151 Stagecoach Trail, Suite 220, San Marcos
4.4(352 Google reviews)
United States
8 listed treatment centers serving San Marcos and the surrounding area.
151 Stagecoach Trail, Suite 220, San Marcos
4.4(352 Google reviews)
151 Stagecoach Trail, Suite 220, San Marcos
4.4(65 Google reviews)
151 Stagecoach Trail, Suite 220, San Marcos
4.6(52 Google reviews)
151 Stagecoach Trail, Suite 220, San Marcos
5.0(33 Google reviews)
151 Stagecoach Trail, Suite 220, San Marcos
5.0(2 Google reviews)
For people in San Marcos considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the prescribed schedule. Ask for an estimate that includes both the medication and the observed treatment and monitoring visit: these may be billed separately. An estimate is not a guarantee of what your insurer will pay.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials before deciding whether to approve treatment. Ask the center which records are needed, whether your previous prescriber should send them, and who will handle the authorization paperwork. Confirm approval before scheduling treatment, and ask whether continued visits require renewed authorization.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. These general possibilities do not establish that a San Marcos center accepts your coverage; confirm participation with both the center and your insurer.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Eligibility rules apply, and assistance may not cover every charge associated with a visit. Ask about current terms rather than assuming you qualify.
Before starting, ask:
SPRAVATO® must be given in a REMS-certified healthcare setting. You self-administer the nasal spray under direct observation of a healthcare provider; it is never taken home. This directory lists eight San Marcos centers offering Spravato, but their REMS certification is not confirmed in the supplied listings. Verify current certification and appointment availability directly before making plans.
The typical labeled schedule for treatment-resistant depression starts with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume that everyone follows the same long-term timetable.
Plan for at least two hours of monitoring after each dose, plus time for check-in, preparation, and discharge assessment. A visit may take longer depending on how you feel and the team's safety assessment. Ask for the full expected appointment window when arranging time off work, childcare, or other responsibilities.
You need someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every visit, identify a backup driver, and ask the center about its pickup requirements. Consider next-day transportation if you have not slept restfully.
If no San Marcos listing is available when you search, or local centers cannot accommodate you, this directory also lists centers in Austin and San Antonio. Confirm certification, availability, and insurance participation before committing to travel. Choose a location you can realistically reach repeatedly with dependable transportation home.
This directory lists eight San Marcos centers offering SPRAVATO®, but the listings do not confirm REMS certification. Contact a center and ask whether it is currently certified to administer Spravato, is accepting patients, and can evaluate your needs. If local appointments are unavailable, you can also review listings in Austin or San Antonio and verify those details directly.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and safety considerations to determine whether it is appropriate.
Coverage depends on your plan and treatment setting. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask your insurer and the center to confirm network participation, medication coverage, monitoring charges, and your expected share of costs. Medicare and Texas Medicaid may cover treatment depending on the plan and setting, but that does not mean every listed center accepts them.
You administer the nasal spray yourself under a healthcare provider's direct observation in a REMS-certified setting. After the dose, the team monitors you for at least two hours for effects such as sedation, dissociation, breathing problems, and blood pressure increases. You are assessed before leaving and need someone else to take you home. The medication is never supplied for home use.
Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can feel like being disconnected from yourself or your surroundings. Blood pressure can also rise. It is a Schedule III controlled substance. Discuss your medical history, medications, and substance use history openly with the prescriber, and report concerning symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. For immediate danger or a medical emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.